• shareholder alert: weiss law reminds eq, imgo, mtcr, and opnt shareholders about its ongoing investigations Marketscreener.com Fri, 28 Feb 2025 12:35:26 GMT
• Organovo Offloads FXR Agonist Portfolio To Lilly insights.citeline.com Tue, 25 Feb 2025 08:00:00 GMT
• metacrine enters collaboration with novo nordisk to develop fgf 1 variants for glucose lowering, insulin sensitization Reuters.com Thu, 15 Aug 2024 07:00:00 GMT
• non-alcoholic fatty liver disease pipeline and clinical trials openPR Wed, 12 Jun 2024 20:42:00 GMT
• metacrine accelerates met409 clinical development milestone and reports first-quarter 2021 results br.ADVFN.com Fri, 07 Jun 2024 06:40:30 GMT
• FXR314 well tolerated, lowers liver fat, Phase 2 MASH trial shows Liver Disease News Mon, 22 Apr 2024 07:00:00 GMT
• shareholder alert: weiss law investigates equillium, inc. The Globe and Mail Fri, 19 Apr 2024 00:46:08 GMT
• metacrine investor alert by the former attorney general of louisiana: kahn swick & foti, llc investigates ... The Globe and Mail Fri, 19 Apr 2024 00:44:49 GMT
• can organovo leverage its solid phase ii data in mash? Citeline News & Insights Tue, 16 Apr 2024 07:00:00 GMT
• metacrine announces date of fourth quarter and full year 2020 financial results conference call The Globe and Mail Wed, 10 Apr 2024 16:58:02 GMT
• metacrine choosing between two nash fxr agonists it calls best-in-class Scrip Fri, 05 Apr 2024 03:42:42 GMT
• equillium inc to acquire metacrine inc - m&a call transcript GuruFocus.com Tue, 06 Feb 2024 08:00:00 GMT
• Velia Therapeutics Appoints Michael York as Chief Business Officer PR Newswire Thu, 14 Dec 2023 08:00:00 GMT
• tff pharmaceuticals appoints catherine lee, j.d. to board of directors citybiz Thu, 30 Nov 2023 08:00:00 GMT
• development of a model including mri features for predicting ... RSNA Publications Online Tue, 07 Nov 2023 08:00:00 GMT
• nonalcoholic steatohepatitis (nash) market to observe stunning ... BioSpace Wed, 01 Nov 2023 07:00:00 GMT
• early diagnosis, treatment intensification essential to improve ... Healio Tue, 24 Oct 2023 07:00:00 GMT
• pegozafermin improves fibrosis in patients with nash, could ... Healio Fri, 22 Sep 2023 07:00:00 GMT
• biotech firm nearing completion of indy radioisotopes factory ... Inside INdiana Business Mon, 18 Sep 2023 07:00:00 GMT
• $9.5 million novo nordisk grant to fund trial of ozempic, wegovy for ... Healio Tue, 29 Aug 2023 07:00:00 GMT
• clinical trial studying possible new treatment option for patients ... UC San Diego Health Wed, 23 Aug 2023 07:00:00 GMT
• regulus therapeutics reports second quarter 2023 financial ... PR Newswire Tue, 08 Aug 2023 07:00:00 GMT
• crohn's disease pipeline assessment (2023) covering clinical trials, emerging therapies, fda, ema, and pmda ap openPR Mon, 31 Jul 2023 07:00:00 GMT
• seladelpar efficacy and safety at 3 months in patients with ... LWW Journals Thu, 20 Jul 2023 06:17:22 GMT
• leaven partners second quarter 2023 letter to partners Seeking Alpha Mon, 17 Jul 2023 07:00:00 GMT
• irritable bowel syndrome market to exhibit growth at a cagr of 9.3 ... PR Newswire Mon, 17 Jul 2023 07:00:00 GMT
• neuer oraler glp-1-agonist – therapie von adipositas und typ-2 ... Medscape Mon, 10 Jul 2023 07:00:00 GMT
• type 2 diabetes, hepatic decompensation, and hepatocellular ... The Lancet Tue, 04 Jul 2023 07:00:00 GMT
• un nouvel agoniste glp-1 oral prometteur dans l'obésité et le dt2 Medscape Tue, 04 Jul 2023 07:00:00 GMT
• study: potential new treatment identified for liver disease UC San Diego Health Mon, 26 Jun 2023 07:00:00 GMT
• statin use and risk of liver disease, hepatocellular carcinoma ... JAMA Network Mon, 26 Jun 2023 07:00:00 GMT
• daily business report: june 26, 2023, san diego metro magazine San Diego Metropolitan Mon, 26 Jun 2023 07:00:00 GMT
• combined glp-1/amylin analog bests monotherapy for hba1c drop ... Healio Sun, 25 Jun 2023 07:00:00 GMT
• a multisociety delphi consensus statement on new fatty... : hepatology LWW Journals Sat, 24 Jun 2023 07:00:00 GMT
• regulus therapeutics announces appointment of preston s ... PR Newswire Fri, 23 Jun 2023 07:00:00 GMT
• 'game changer' in nash: resmetirom hits endpoints in pivotal study Medpage Today Thu, 22 Jun 2023 07:00:00 GMT
• Ex-Metacrine chief Preston Klassen recharges at microRNA biotech; Allogene begins search for a CFO Endpoints News Fri, 16 Jun 2023 07:00:00 GMT
• crohn's disease clinical trial pipeline insights | 90+ key ... Medgadget Tue, 06 Jun 2023 07:00:00 GMT
• performance of non-invasive tests and histology for the prediction of ... The Lancet Mon, 05 Jun 2023 07:00:00 GMT
• nonalcoholic steatohepatitis market evolving at a rapid pace ... PR Newswire Mon, 24 Apr 2023 07:00:00 GMT
• delveinsight highlights major advances, transformative therapies, and 80+ leading players wheeling the crohn's disease pipeline la... Yahoo Finance Mon, 17 Apr 2023 07:00:00 GMT
• global epidemiology of cirrhosis — aetiology, trends and predictions Nature.com Tue, 28 Mar 2023 07:00:00 GMT
• biomarkers for staging fibrosis and non-alcoholic steatohepatitis in ... The Lancet Mon, 20 Mar 2023 07:00:00 GMT
• semaglutide 2·4 mg once weekly in patients with non-alcoholic ... The Lancet Thu, 16 Mar 2023 07:00:00 GMT
• primis: design of a pivotal, randomized, phase 3 study evaluating ... BMC Gastroenterology Wed, 15 Mar 2023 07:00:00 GMT
• nasdaq to delist shares of waitr and calithera biosciences, among others Seeking Alpha Wed, 01 Mar 2023 08:00:00 GMT
• delisting of securities of eqonex limited; scopus biopharma inc ... Yahoo Finance Wed, 01 Mar 2023 08:00:00 GMT
• possible nafld name change must benefit both patients, field of ... Healio Mon, 20 Feb 2023 08:00:00 GMT
• metacrine, inc. : notice of delisting or failure to satisfy a ... Marketscreener.com Wed, 01 Feb 2023 21:20:30 GMT
• irritable bowel syndrome pipeline booms as 24+ therapies likely ... GlobeNewswire Wed, 18 Jan 2023 08:00:00 GMT
• Deal Watch: AbbVie Leads J.P. Morgan Deal Rush, But BI, Genentech And Lilly Also Big Players insights.citeline.com Wed, 11 Jan 2023 08:00:00 GMT
• fierce biotech layoff tracker: layoffs strike 119 companies in 2022 FierceBiotech Tue, 03 Jan 2023 08:00:00 GMT
• delveinsight evaluates a robust nonalcoholic fatty liver disease pipeline as 110+ influential pharma players to set ... GlobeNewswire Mon, 02 Jan 2023 08:00:00 GMT
• 2022 turns out to be another unspectacular year for pharma and ... The Pharma Letter Mon, 02 Jan 2023 08:00:00 GMT
• from physician to leader in global research and development Journal of Nuclear Medicine Sun, 01 Jan 2023 08:00:00 GMT
• news wrap: equillium axes metacrine merger; two pharmas pen adc deals Endpoints News Thu, 29 Dec 2022 08:00:00 GMT
• Equillium cancels Metacrine buy, citing 'strong financial position' after Ono deal Fierce Biotech Tue, 27 Dec 2022 08:00:00 GMT
• equillium is no longer buying metacrine, citing new cash Fierce Biotech Tue, 27 Dec 2022 08:00:00 GMT
• Metacrine and Equillium Mutually Agree to Terminate Definitive Merger Agreement GlobeNewswire Fri, 23 Dec 2022 08:00:00 GMT
• equillium and metacrine mutually agree to terminate definitive merger agreement Business Wire Fri, 23 Dec 2022 08:00:00 GMT
• equillium’s partner biocon initiates phase 2 study of itolizumab in ulcerative colitis Business Wire Fri, 16 Dec 2022 08:00:00 GMT
• metacrine stock: potential play on a higher bid (nasdaq:mtcr) Seeking Alpha Thu, 15 Dec 2022 08:00:00 GMT
• shareholder alert: weiss law reminds eq, imgo, mtcr, and opnt shareholders about its ongoing investigations Marketscreener.com Wed, 07 Dec 2022 08:00:00 GMT
• autoimmune biotech scores $26m payment, up to $139m to advance phase 3 research Yahoo Finance Tue, 06 Dec 2022 08:00:00 GMT
• equillium and ono pharmaceutical announce exclusive option and asset purchase agreement for the development ... Business Wire Tue, 06 Dec 2022 08:00:00 GMT
• recode therapeutics appoints trisha millican to board of directors Business Wire Thu, 01 Dec 2022 08:00:00 GMT
• resmetirom reduces liver, cv risk factors in nash with cirrhosis Medscape Mon, 07 Nov 2022 08:00:00 GMT
• california biotech to invest $45m in indy, hire 64 people – inside indiana business Inside INdiana Business Tue, 01 Nov 2022 07:00:00 GMT
• study: first-degree relatives of patients with nafld at risk of liver ... UC San Diego Health Tue, 01 Nov 2022 07:00:00 GMT
• metacrine, inc. enters into a license agreement with fl2022-001, inc Marketscreener.com Tue, 11 Oct 2022 07:00:00 GMT
• shareholder investigation: halper sadeh llc investigates gmtx, smbc, eq, mtcr GlobeNewswire Thu, 22 Sep 2022 07:00:00 GMT
• fasn inhibition targets multiple drivers of nash by reducing ... Nature.com Mon, 19 Sep 2022 07:00:00 GMT
• Equillium sees $26M Metacrine buy as opportunity to boost its balance sheet Fierce Biotech Wed, 07 Sep 2022 07:00:00 GMT
• A Rich Heyman biotech backed by a top Salk scientist is auctioned off for its dwindling cash reserves Endpoints News Wed, 07 Sep 2022 07:00:00 GMT
• acquisitive roche, equillium sink funds into il-2 and gi drugs BioSpace Wed, 07 Sep 2022 07:00:00 GMT
• wilson sonsini advises metacrine on acquisition by equillium Wilson Sonsini Wed, 07 Sep 2022 07:00:00 GMT
• equillium buys inflammatory bowel disease player in all-stock deal Yahoo Finance Wed, 07 Sep 2022 07:00:00 GMT
• equillium buys struggling metacrine in $26m all-stock deal Fierce Biotech Wed, 07 Sep 2022 07:00:00 GMT
• sept. 7 quick takes: arch-backed orbital launches with rna platform BioCentury Wed, 07 Sep 2022 07:00:00 GMT
• Equillium to Acquire Metacrine in All-Stock Transaction Business Wire Tue, 06 Sep 2022 07:00:00 GMT
• eq stock alert: halper sadeh llp is investigating whether the merger of equillium, inc. is fair to shareholders Business Wire Tue, 06 Sep 2022 07:00:00 GMT
• impact of semaglutide on high-sensitivity c-reactive protein ... Cardiovascular Diabetology Fri, 02 Sep 2022 07:00:00 GMT
• hepatologists, gastroenterologists lead nash diagnosis yet ... Healio Wed, 10 Aug 2022 07:00:00 GMT
• imaging features of premalignant biliary lesions and predisposing ... RSNA Publications Online Fri, 05 Aug 2022 07:00:00 GMT
• as pharma's nash failures pile up, regeneron thinks it found the target that matters Fierce Biotech Tue, 02 Aug 2022 07:00:00 GMT
• regeneron researchers identify promising new nash target Fierce Biotech Tue, 02 Aug 2022 07:00:00 GMT
• nonalcoholic steatohepatitis medical patient journey from the ... BMC Gastroenterology Sun, 10 Jul 2022 07:00:00 GMT
• resmetirom 'has potential to be first medication approved' for ... Healio Tue, 05 Jul 2022 07:00:00 GMT
• low-carb, high-fat diet improves a1c, reduces liver fat: study Medscape Mon, 27 Jun 2022 07:00:00 GMT
• pfizer supports akero's nash dreams with $25m investment FierceBiotech Thu, 16 Jun 2022 07:00:00 GMT
• Chutes & Ladders—Forte taps Chen to be president, CSO amid shareholder dissent Fierce Biotech Fri, 10 Jun 2022 07:00:00 GMT
• causes of liver cancer are changing around the world: some up ... UC San Diego Health Mon, 06 Jun 2022 07:00:00 GMT
• salk institute welcomes biopharmaceutical executive carol ... Salk Institute Tue, 10 May 2022 07:00:00 GMT
• newly defined liver disorder associated with covid mortality Medscape Tue, 03 May 2022 07:00:00 GMT
• do analysts expect metacrine inc (mtcr) stock to rise after it is down -18.03% in a month? InvestorsObserver Fri, 22 Apr 2022 07:00:00 GMT
• direct comparison of quantitative us versus controlled attenuation ... RSNA Publications Online Tue, 29 Mar 2022 07:00:00 GMT
• 89bio gains a little more confidence in nash treatment with new ... FierceBiotech Fri, 25 Mar 2022 07:00:00 GMT
• metacrine inc. (nasdaq: mtcr) on track to begin second phase clinical study of met642 in ulcerative colitis BP Journal Thu, 03 Mar 2022 08:00:00 GMT
• Metacrine lays off half its staff, mainly researchers, and ditches more work to focus on IBD after NASH disaster Fierce Biotech Fri, 11 Feb 2022 08:00:00 GMT
• Rich Heyman-backed biotech gets out the axe as it sets course on survival mission Endpoints News Fri, 11 Feb 2022 08:00:00 GMT
• metacrine, inc. remains on track to begin a phase 2 clinical trial in ulcerative colitis Marketscreener.com Fri, 11 Feb 2022 08:00:00 GMT
• metacrine updates ibd clinical development strategy and implements restructuring plan GlobeNewswire Fri, 11 Feb 2022 08:00:00 GMT
• herbal products for ibs; liver transplant, diabetes, and cancer; ibd work impairment Medpage Today Fri, 11 Feb 2022 08:00:00 GMT
• dr. hubert chen joins adarx pharmaceuticals as chief medical officer Business Wire Wed, 05 Jan 2022 08:00:00 GMT
• metacrine inc shares fall 8.3% below previous 52-week low - market mover Nasdaq Thu, 23 Dec 2021 08:00:00 GMT
• Bristol Myers becomes latest victim of unforgiving NASH as midstage asset shelved Fierce Biotech Thu, 18 Nov 2021 08:00:00 GMT
• is metacrine inc (mtcr) stock a bad value tuesday? InvestorsObserver Tue, 16 Nov 2021 08:00:00 GMT
• should you hold metacrine inc (mtcr) stock friday morning? InvestorsObserver Fri, 05 Nov 2021 07:00:00 GMT
• sorrento therapeutics inc. (nasdaq: srne) receives ce mark ... BP Journal Fri, 05 Nov 2021 07:00:00 GMT
• metacrine inc. (nasdaq: mtcr) reports preliminary phase 2a study results evaluating met642 in nash patients BP Journal Thu, 04 Nov 2021 07:00:00 GMT
• metacrine reports topline results for met409 phase 2a combination trial in patients with type 2 diabetes and nash GlobeNewswire Tue, 02 Nov 2021 07:00:00 GMT
• Metacrine shares halved as NASH program nixed on mixed bag data and early safety issue Fierce Biotech Fri, 22 Oct 2021 07:00:00 GMT
• metacrine cut to neutral at h.c. wainwright as company's nash program ends Seeking Alpha Fri, 22 Oct 2021 07:00:00 GMT
• u.s. stocks mixed at close of trade; dow jones industrial average up 0.21% by investing.com Investing.com Fri, 22 Oct 2021 07:00:00 GMT
• Metacrine Reports Interim Results for MET642 Phase 2a Trial GlobeNewswire Thu, 21 Oct 2021 07:00:00 GMT
• should you accumulate metacrine inc (mtcr) stock tuesday morning? InvestorsObserver Tue, 28 Sep 2021 07:00:00 GMT
• metacrine achieves full enrollment for met642 phase 2a trial in patients with nash GlobeNewswire Thu, 09 Sep 2021 07:00:00 GMT
• metacrine to host virtual r&d day for analysts and investors on september 15, 2021 GlobeNewswire Wed, 08 Sep 2021 07:00:00 GMT
• fatty liver still unseen in the metabolic 'constellation of risk' Healio Mon, 23 Aug 2021 07:00:00 GMT
• axa1125 safe, well tolerated up to 16 weeks in patients with nafld Healio Tue, 17 Aug 2021 07:00:00 GMT
• cause for optimism in stubborn problem of intestinal fibrosis Gastroenterology & Endoscopy News Wed, 11 Aug 2021 07:00:00 GMT
• surpass-2: tirzepatide bests semaglutide in hba1c reduction ... Healio Fri, 25 Jun 2021 07:00:00 GMT
• metacrine and its partners to present data at the easl international liver congress™ 2021 GlobeNewswire Thu, 17 Jun 2021 07:00:00 GMT
• metacrine achieves full enrollment for met409 phase 2a combination trial in patients with type 2 diabetes and nash GlobeNewswire Wed, 02 Jun 2021 07:00:00 GMT
• metacrine to present at 2021 jefferies healthcare conference GlobeNewswire Wed, 26 May 2021 07:00:00 GMT
• metacrine to present new preclinical data on met642 in inflammatory bowel disease at digestive disease week ... Yahoo Finance Wed, 19 May 2021 07:00:00 GMT
• global irritable bowel syndrome pipeline insight report 2021 ... Business Wire Thu, 13 May 2021 07:00:00 GMT
• bio89-100 reduces liver fat, lowers triglycerides in adults with nash Healio Tue, 30 Mar 2021 07:00:00 GMT
• a myriad of drugs are in the pipeline for ulcerative colitis treatment ... GlobeNewswire Tue, 30 Mar 2021 07:00:00 GMT
• a placebo-controlled trial of subcutaneous semaglutide in ... nejm.org Thu, 25 Mar 2021 07:00:00 GMT
• a structurally optimized fxr agonist, met409, reduced liver fat content over 12 weeks in patients with non-alcoholic ... ScienceDirect.com Thu, 11 Feb 2021 20:50:56 GMT
• rayzebio debuts with $45m to target tumors with radiopharmaceuticals Fierce Biotech Wed, 14 Oct 2020 07:00:00 GMT
• ipo calendar: october 12 - 16, 2020 - ipos on thestreet - u.s. ipo research & opinion TheStreet Fri, 09 Oct 2020 19:44:24 GMT
• q&a: new breath test adds hydrogen sulfide to better understand ... Healio Tue, 29 Sep 2020 07:00:00 GMT
• wilson sonsini advises metacrine on ip matters related to initial public offering Wilson Sonsini Mon, 28 Sep 2020 07:00:00 GMT
• metacrine's stock debuts with an 11% gain above its ipo price MarketWatch Wed, 16 Sep 2020 07:00:00 GMT
• metacrine announces pricing of initial public offering GlobeNewswire Tue, 15 Sep 2020 07:00:00 GMT
• ipo outlook for the week: snowflake and amwell lead busy 12 ipo lineup - snowflake (nyse:snow) Benzinga Sun, 13 Sep 2020 07:00:00 GMT
• ipo update: metacrine seeks $85 million u.s. ipo (otcmkts:mtcr-defunct-605284) Seeking Alpha Fri, 11 Sep 2020 07:00:00 GMT
• mtcr ipo news - nash biotech metacrine sets terms for $85 million ipo Renaissance Capital Wed, 09 Sep 2020 07:00:00 GMT
• nash biotech metacrine sets terms for $85 million ipo Renaissance Capital Wed, 09 Sep 2020 07:00:00 GMT
• metacrine seeks u.s. ipo for nash pipeline advance (otcmkts:mtcr) Seeking Alpha Wed, 02 Sep 2020 07:00:00 GMT
• novel antisense drug shows promise in slowing fatty liver disease UC San Diego Health Tue, 16 Jun 2020 07:00:00 GMT
• what is the ace2 receptor, how is it connected to coronavirus and ... The Conversation Indonesia Thu, 14 May 2020 07:00:00 GMT
• metabolic risk factors and incident advanced liver disease in non ... PLOS Thu, 30 Apr 2020 07:00:00 GMT
• the 2020 midas brink list: meet venture capital's up-and-comers Forbes Tue, 14 Apr 2020 07:00:00 GMT
• aacr foundation leadership | governance American Association for Cancer Research (AACR) Fri, 07 Feb 2020 16:03:48 GMT
• metacrine demonstrates best-in-class fxr drug program with positive clinical results in nash patients PR Newswire Wed, 22 Jan 2020 08:00:00 GMT
• roth capital partners to host roth battle of the nash thrones ... Business Wire Thu, 21 Mar 2019 07:00:00 GMT
• alexandria real estate equities, inc. announces the launch of ... PR Newswire Thu, 28 Feb 2019 08:00:00 GMT
• amunix announces appointment of dr. angie you as chief ... Business Wire Thu, 03 Jan 2019 08:00:00 GMT
• baltimore longitudinal study of aging: how to live forever or die trying BioSpace Mon, 12 Nov 2018 08:00:00 GMT
• sd 500 update: reality changers founder steps down after 17 years San Diego Business Journal Thu, 25 Oct 2018 07:00:00 GMT
• elevian launches to join numerous companies focused on longevity and aging BioSpace Mon, 10 Sep 2018 07:00:00 GMT
• elevian launches to join numerous companies focused on longevity and aging BioSpace Fri, 07 Sep 2018 07:00:00 GMT
• free biotech stocks directory, pharma stocks, telemedicine stocks ... InvestorIdeas.com Thu, 30 Aug 2018 18:22:11 GMT
• metacrine raises $65m to kick off nash clinical testing FierceBiotech Wed, 06 Jun 2018 07:00:00 GMT
• metacrine to present at 30th annual roth conference and h.c. wainwright & co. 2nd annual nash investor ... PR Newswire Wed, 07 Mar 2018 08:00:00 GMT
• metacrine completes series b financing to advance best-in-class fxr program into clinical development PR Newswire Thu, 07 Dec 2017 08:00:00 GMT
• metacrine raises $22m to advance liver drug for humans The San Diego Union-Tribune Thu, 07 Dec 2017 08:00:00 GMT
• vividion therapeutics appoints diego miralles, m.d., chief ... PR Newswire Thu, 07 Sep 2017 07:00:00 GMT
• laura deming chce zastavit stárnutí. její fond pro výzkum má na ... Objevit.cz Wed, 06 Sep 2017 07:00:00 GMT
• longevity fund raises cash to back anti-aging startups FierceBiotech Wed, 23 Aug 2017 07:00:00 GMT
• metacrine announces collaboration on development of fgf1 variants for glucose lowering and improving insulin sensitivity BioSpace Tue, 15 Aug 2017 07:00:00 GMT
• serial startup scientist ronald evans tests a new mighty mouse drug, making marathon runners with a pill Endpoints News Thu, 04 May 2017 07:00:00 GMT
• metacrine expands patent portfolio for novel fgf-1 program to treat diabetes PR Newswire Mon, 17 Oct 2016 07:00:00 GMT
• ken song named president/ceo of biotech metacrine inc. San Diego Business Journal Wed, 14 Sep 2016 07:00:00 GMT
• metacrine announces appointment of dr. ken song as president and chief executive officer PR Newswire Wed, 14 Sep 2016 07:00:00 GMT
• venbio closes $315 million life sciences venture capital fund PR Newswire Fri, 06 May 2016 07:00:00 GMT
• biotech startup metacrine raises $36 million - the san diego union-tribune The San Diego Union-Tribune Wed, 05 Aug 2015 07:00:00 GMT
Metacrine, Inc(NASDAQ:MTCR) 
Metacrine, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing therapies for patients with liver and gastrointestinal diseases. It is developing MET409 that has completed Phase 1b proof-of-concept clinical trial for the treatment of patients with non-alcoholic ste...
Website: http://www.metacrine.com
Founded: 2014
CEO: Preston S. Klassen
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends